Cerus Corporation
Clinical trials sponsored by Cerus Corporation, explained in plain language.
-
New blood treatment could block zika in transfusions
Disease control OngoingThis study tests a special treatment for red blood cells that aims to kill the Zika virus, making transfusions safer. About 692 people who need blood transfusions will receive either treated or standard blood. The goal is to see if the treated blood works just as well and is safe…
Phase: PHASE3 • Sponsor: Cerus Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Sickle cell blood study pulled before it began
Knowledge-focused TerminatedThis study was designed to see how long specially treated red blood cells survive in adults with sickle cell disease who receive regular blood exchange therapy. It was withdrawn before any participants were enrolled, so no results are available. The goal was to better understand …
Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC